Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-15 · accession 0001214659-22-008169 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-17 | 2022-06-15 | ALLO | WITTE OWEN N. | Dir | A - Grant | $0.00 | +22.1K | 243.3K | +10% | $0 |
| D | 2022-06-17 | 2022-06-15 | ALLO | WITTE OWEN N. | Dir | A - Grant | $0.00 | +35.5K | 35.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-15 | A | A | 22,089 | $0.00 | 243,271 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-15 | A | A | 35,535 | $0.00 | 35,535 | D | $9.62 · — to 2032-06-15 | 35,535 Common Stock | (F1) Vesting in 12 equal monthly installments. |